研究業績
2024年
Original Article
Imai H, Kijima T, Azuma K, Kishi K, Saito H, Yamaguchi T, Tanizaki J, Yoneshima Y, Fujita K, Watanabe S, Kitazono S, Fukuhara T, Hataji O, Toi Y, Mizutani H, Hamakawa Y, Maemondo M, Ohsugi T, Suzuki K, Horinouchi H, Ohe Y. : First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer: LIGHT-NING study. Katayama Y, Yamada T, Sawada R, Kawachi H, Morimoto K, Watanabe S, Watanabe K, Takeda T, Chihara Y, Shiotsu S, Hibino M, Harada T, Nishioka N, Iwasaku M, Tokuda S, Takayama K. : Prospective Observational Study of Ramucirumab Plus Docetaxel After Combined Chemoimmunotherapy in Patients With Non-Small-Cell Lung Cancer. Moro H, Aoki N, Matsumoto H, Tone K, Shuto H, Komiya K, Kikuchi T, Shime N. : Bacterial Profiles Detected in Ventilator-Associated Pneumonia in Japan: A Systematic Review Morimoto K, Yamada T, Hirai S, Katayama Y, Fukui S, Sawada R, Tachibana Y, Matsui Y, Nakamura R, Ishida M, Kawachi H, Kunimasa K, Sasaki T, Nishida M, Furuya N, Watanabe S, Shiotsu S, Nishioka N, Horinaka M, Sakai T, Uehara H, Yano S, Son BK, Tokuda S, Takayama K. : AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells. Watanabe S, Yoshioka H, Sakai H, Hotta K, Takenoyama M, Yamada K, Sugawara S, Takiguchi Y, Hosomi Y, Tomii K, Niho S, Nishio M, Kato T, Takahashi T, Ebi H, Aono M, Yamamoto N, Ohe Y, Nakagawa K. : Association between skin toxicity and efficacy of necitumumab in squamous non-small-cell lung cancer: a pooled analysis of two randomized clinical trials-SQUIRE and JFCM Hu Z, Wang N, Zhang Y, Zhang D, Sun S, Yu H, Lin Y, Zhao X, Wang H, Wu X, Ichiki Y, Watanabe S, Gong Z, Chang J, Wang J. : PD-L1 mRNA derived from tumor-educated platelets as a potential immunotherapy biomarker in non-small cell lung cancer. Mouri A, Watanabe S, Tokito T, Nagai Y, Saida Y, Imai H, Yamaguchi O, Kobayashi K, Kaira K, Kagamu H. : Clinical Outcome of Nivolumab Plus Ipilimumab in Patients with Locally Advanced Non-Small-Cell Lung Cancer with Relapse after Concurrent Chemoradiotherapy followed by Durvalumab. Akasaka K, Amano M, Nakamura T, Nishizawa T, Yamakawa H, Sato S, Aoki A, Shima K, Matsushima H, Takada T. : Cytokine profiles associated with disease severity and prognosis of autoimmune pulmonary alveolar proteinosis Ozeki Y, Yokoyama A, Yoshida Y, Ohara Y, Mashima T, Tomiyama C, Shaban AK, Takeishi A, Osada-Oka M, Yamaguchi T, Tateishi Y, Maeyama J, Hakamata M, Moro H, Kikuchi T, Hayashi D, Suzuki F, Yamamoto T, Iho S, Katahira M, Tamamoto S, Matsumoto S. : Recombinant Mycobacterial DNA-binding Protein 1 with post-translational modifications boosts IFN-gamma production from BCG-vacctinated individual's blood cells in combination with CpG-DNA Tozuka T, Minegishi Y, Yamaguchi O, Watanabe K, Toi Y, Saito R, Nagai Y, Tamura Y, Shoji T, Odagiri H, Ebi N, Sakai K, Kanaji N, Izumi M, Soda S, Watanabe S, Morita S, Kobayashi K, Seike M. : Immunotherapy With Radiotherapy for Brain Metastases in Patients With NSCLC: NEJ060. Asao T, Shukuya T, Uemura K, Kitadai R, Yamamoto G, Mouri A, Tamaoka M, Imai R, Tsukita Y, Isobe K, Watanabe S, Kamimura M, Morita R, Kudo K, Inomata M, Tateishi K, Kakinuma K, Yoshioka H, Namba Y, Sumiyoshi I, Nakagawa T, Watanabe K, Kobayashi K, Takahashi K. Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint blockade therapy: Survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospective study (NEJ047). Nishio M, Watanabe S, Udagawa H, Aragane N, Nakagawa Y, Kobayashi Y, Saito H. : Integrated analysis of older adults and patients with renal dysfunction in the IMpower130 and IMpower132 randomized controlled trials for advanced non-squamous non-small cell lung cancer. Yamagishi I, Bamba Y, Moro H, Kanno N, Tsuruma H, Hakamata M, Ogata H, Shibata S, Aoki N, Ohshima Y, Watanabe S, Koya T, Kikuchi T. : Retrospective Comparison of Two Aspergillus IgG Enzyme Immunoassays for Diagnosing Pulmonary Aspergillosis Takeda N, Koya T, Hasegawa T, Tanaka M, Matsuda T, Murai Y, Naramoto S, Kimura Y, Shima K, Kurokawa M, Aoki A, Yoshida C, Sakagami T, Maruoka S, Gon, Y Kikuchi T. ; Niigata Asthma Treatment Study Group. : Prevalence and characteristics of dysfunctional breathing in patients with asthma in the Japanese population Yamazaki M, Watanabe S*, Tominaga M, Yagi T, Goto Y, Yanagimura N, Arita M, Ohtsubo A, Tanaka T, Nozaki K, Saida Y, Kondo R, Kikuchi T, Ishikawa H. : 18F-FDG-PET/CT Uptake by Noncancerous Lung as a Predictor of Interstitial Lung Disease Induced by Immune Checkpoint Inhibitors. Miura K, Shukuya T, Furuya N, Morita R, Kisohara A, Mouri A, Watanabe S, Tanaka H, Hirata A, Hakozaki T, Hamai K, Matsumoto N, Watanabe K, Ashinuma H, Miyauchi E, Sugano K, Hosokawa S, Amano K, Morita S, Kobayashi K, Maemonodo M, Takahashi K. : Impact of Cachexia and First-Line Systemic Therapy for Previously Untreated Advanced Non-Small Cell Lung Cancer: NEJ050A. Saito A, Koya T, Aoki A, Naramoto S, Ueno H, Nishiyama Y, Shima K, Kimura Y, Hasegawa T, Watanabe S, Ohshima Y, Suzuki K, Ohashi-Doi K, Kikuchi T. : Mechanism differences in the start time of sublingual immunotherapy in a mouse allergic airway inflammation model Tanaka T, Goto Y, Masuda K, Shinno Y, Matsumoto Y, Okuma Y, Yoshida T, Horinouchi H, Yamamoto N, Ohe Y. : The remarkable antitumor efficacy of corticosteroid treatment in patients with refractory thymomas Nishioka N, Hata T, Yamada T, Goto Y, Amano A, Negi Y, Watanabe S, Furuya N, Oba T, Ikoma T, Nakao A, Tanimura K, Taniguchi H, Yoshimura A, Fukui T, Murata D, Kaira K, Shiotsu S, Hibino M, Okada A, Chihara Y, Kawachi H, Kijima T, Takayama K. : Impact of TTF-1 Expression on the Prognostic Prediction of Patients with NSCLC with PD-L1 Expression Levels of 1% to 49%, Treated with Chemotherapy vs Chemoimmunotherapy: A Multicenter, Retrospective Study. Katayama Y, Yamada T, Tanimura K, Kawachi H, Ishida M, Matsui Y, Hirai S, Nakamura R, Morimoto K, Furuya N, Arai S, Goto Y, Sakata Y, Nishino K, Tsuchiya M, Tamiya A, Saito G, Muto S, Takeda T, Date K, Fujisaka Y, Watanabe S, Fujimoto D, Uehara H, Horinaka M, Sakai T, Yano S, Tokuda S, Takayama K. : YAP regulates HER3 signaling-driven adaptive resistance to RET inhibitors in RET-aberrant cancer.
Case Report
Tanaka K, Kimura Y, Aoki A, Toyama-Kousaka M, Shima K, Koya T, Kikuchi T. : Successful Treatment with Mycophenolate Mofetil in a Patieint with Anti-MDA 5 Antibody-positive Interstitial Lung Disease and Posterior Reversible Encephalopathy syndrome: A Case Report Yanagiya M, Kazama Y, Yang SM, Lal A, Russo R, Watanabe S, Wada A, Furuhata Y, Nakajima J. : Intrapleural minocycline pleurodesis for bilateral pneumothorax due to septic pulmonary embolism: a case report. Suzuki S, Hayashi R, Sato M, Higuchi M, Kase Y, Takei S, Oginezawa M, Kawai T, Kanno N, Ogata H, Shibata S, Bamba Y, Abe R. : A case of Japanese spotted fever with purpura fulminans
Review
Editorial
和文総説
高田俊範 : 肺胞蛋白症宇井雅博、柴田怜、菊地利明 : 再発性多発軟骨炎の治療中に発症したMycobacterium chelonaeによる血流感染の1例岩﨑円、韮澤紀文、穂苅諭、大嶋康義、髙橋敦宣、永井明日香、上路拓美、菊地利明、木村慎二 : Platypnea-orthodeoxia症候群の食道胃接合部癌症例に対する周術期リハビリテーション木村陽介、坂上拓郎 : COPD（慢性閉塞性肺疾患/肺気腫）大嶋康義 : 過換気症候群大嶋康義 : 睡眠時無呼吸症候群大嶋康義 : 肺胞低換気症候群大嶋康義 : 治療時出現中枢性睡眠時無呼吸高田俊範 : じん肺 ４）溶接工肺穂苅諭、大嶋康義、菊地利明 : 睡眠時無呼吸症候群の現状と展望
受賞・表彰
福田祐輝（指導：穂苅諭） : 令和5年度新潟大学学生表彰村上このか（指導：野嵜幸一郎） : 第92回呼吸器合同北陸地方会研修医セッション優秀演題賞福田祐輝（指導：穂苅諭） : 令和6年度《第12回》有壬記念医学生研究奨励賞藤間晴也（指導医：宇井雅博） : 第155回日本内科学会信越地方会若手奨励賞篠原陽介（指導：才田優） : 第94回呼吸器合同北陸地方会研修医セッション優秀演題賞
